protoporphyrin ix has been researched along with Erythrohepatic Protoporphyria in 45 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Protoporphyrin IX (PPIX) is an intermediate in the heme biosynthesis pathway." | 3.01 | Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics. ( Anderson, KE; Hussain, Z; Ma, X; Qi, Q; Zhu, J, 2023) |
| " The preference of the subjects could lead to the long-term use of the tested products." | 2.87 | Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria. ( Asano, H; Kamide, R; Kawada, A; Kawara, S; Mizuno, M; Naru, E; Teramura, T, 2018) |
| "Patients with erythropoietic protoporphyria (EPP), an inherited deficiency in FECH, often show signs of iron deficiency in addition to phototoxicity which is caused by PPIX accumulation." | 2.80 | In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability. ( Barman-Aksözen, J; Biolcati, G; Minder, EI; Schneider-Yin, X; Schubiger, C, 2015) |
| "tuberculosis (TB)." | 1.51 | Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. ( Anderson, KE; Balwani, M; Bissel, MD; Bloomer, JR; Desnick, RJ; Gouya, L; Parker, CJ; Phillips, JD; Puy, H; Singal, A, 2019) |
| "Patients with erythropoietic protoporphyria (EPP) have reduced activity of the enzyme ferrochelatase that catalyzes the insertion of iron into protoporphyrin IX (PPIX) to form heme." | 1.46 | Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity. ( Aurizi, C; Barbieri, L; Barman-Aksoezen, J; Biolcati, G; Campostrini, N; Girelli, D; Minder, EI; Schneider-Yin, X, 2017) |
| "According to the clinical features, erythropoietic protoporphyria (EPP) was suspected." | 1.43 | X-linked dominant protoporphyria: The first reported Japanese case. ( Akasaka, E; Kokunai, Y; Moriwaki, S; Nakano, H; Ninomiya, Y; Tanizaki, H, 2016) |
| "Laboratory diagnosis of erythropoietic protoporphyria (EPP) requires a marked increase in total erythrocyte protoporphyrin (300-5000 μg/dL erythrocytes, reference interval <80 μg/dL) and a predominance (85%-100%) of metal-free protoporphyrin [normal, mostly zinc protoporphyrin (reference intervals for the zinc protoporphyrin proportion have not been established)]; plasma porphyrins are not always increased." | 1.42 | Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias. ( Anderson, KE; Balwani, M; Bissell, DM; Bloomer, JR; Bonkovsky, HL; Desnick, RJ; Gou, EW; Keel, S; Naik, H; Phillips, JD; Singal, AK; Wang, B, 2015) |
| "In 90% of people with erythropoietic protoporphyria (EPP), the disease results from the inheritance of a common hypomorphic FECH allele, encoding ferrochelatase, in trans to a private deleterious FECH mutation." | 1.40 | Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria. ( Beaumont, C; de Verneuil, H; Deybach, JC; Ducamp, S; Gouya, L; Grandchamp, B; Guyonnet-Dupérat, V; Karim, Z; Lyoumi, S; Manceau, H; Marie, J; Mirmiran, A; Moreau-Gaudry, F; Oustric, V; Peoc'h, K; Puy, H; Schmitt, C; Soaid, R, 2014) |
| "The PP level of the erythropoietic protoporphyria (EPP) patients was significantly higher than that of healthy volunteers." | 1.38 | A novel rapid method for simultaneous determination of three diagnostically important porphyrins in erythrocytes using hyphenated synchronous fluorescence techniques. ( Huang, W; Li, YQ; Liu, Q; Shindi, AA, 2012) |
| " We have used gene dosage analysis by quantitative PCR to identify large deletions of the FECH gene in 19 (58%) of 33 unrelated UK patients with EPP in whom mutations could not be detected by sequencing." | 1.34 | Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria. ( Anstey, AV; Badminton, MN; Elder, GH; Holme, SA; Mason, NG; Whatley, SD, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (22.22) | 29.6817 |
| 2010's | 26 (57.78) | 24.3611 |
| 2020's | 9 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heerfordt, IM | 5 |
| Fontenete, S | 1 |
| Lerche, CM | 3 |
| Wulf, HC | 7 |
| Hussain, Z | 1 |
| Qi, Q | 1 |
| Zhu, J | 2 |
| Anderson, KE | 4 |
| Ma, X | 2 |
| Parker, CJ | 1 |
| Desnick, RJ | 3 |
| Bissel, MD | 1 |
| Bloomer, JR | 2 |
| Singal, A | 1 |
| Gouya, L | 5 |
| Puy, H | 5 |
| Balwani, M | 4 |
| Phillips, JD | 2 |
| Wang, P | 1 |
| Sachar, M | 1 |
| Lu, J | 1 |
| Shehu, AI | 1 |
| Chen, J | 1 |
| Liu, K | 1 |
| Xie, W | 1 |
| Gonzalez, FJ | 1 |
| Klaassen, CD | 1 |
| Nissen, CV | 1 |
| Philipsen, PA | 2 |
| Heydenreich, J | 1 |
| Wang, Y | 2 |
| Karamchandani, DM | 1 |
| Halloy, F | 2 |
| Iyer, PS | 2 |
| Ghidini, A | 1 |
| Lysenko, V | 1 |
| Barman-Aksözen, J | 3 |
| Grubenmann, CP | 1 |
| Jucker, J | 1 |
| Wildner-Verhey van Wijk, N | 1 |
| Ruepp, MD | 1 |
| Minder, EI | 4 |
| Minder, AE | 2 |
| Schneider-Yin, X | 4 |
| Theocharides, APA | 1 |
| Schümperli, D | 2 |
| Hall, J | 2 |
| Genovese, G | 1 |
| Maronese, CA | 1 |
| Moltrasio, C | 1 |
| Piccinno, R | 1 |
| Marletta, DA | 1 |
| De Luca, G | 1 |
| Graziadei, G | 2 |
| Granata, F | 2 |
| Di Pierro, E | 2 |
| Cappellini, MD | 2 |
| Marzano, AV | 1 |
| Fujimori, N | 1 |
| Komatsu, M | 1 |
| Tanaka, N | 1 |
| Iwaya, M | 1 |
| Nakano, H | 2 |
| Sugiura, A | 1 |
| Yamazaki, T | 1 |
| Shibata, S | 1 |
| Iwaya, Y | 1 |
| Muraki, T | 1 |
| Ichikawa, Y | 1 |
| Kimura, T | 1 |
| Joshita, S | 1 |
| Umemura, T | 1 |
| Matsumoto, A | 1 |
| Tanaka, E | 1 |
| Biewenga, M | 1 |
| Matawlie, RHS | 1 |
| Friesema, ECH | 1 |
| Koole-Lesuis, H | 1 |
| Langeveld, M | 1 |
| Wilson, JHP | 1 |
| Langendonk, JG | 1 |
| Teramura, T | 1 |
| Mizuno, M | 1 |
| Asano, H | 1 |
| Naru, E | 1 |
| Kawara, S | 1 |
| Kamide, R | 1 |
| Kawada, A | 1 |
| Phillips, J | 2 |
| Farrell, C | 1 |
| Singal, AK | 2 |
| Anderson, K | 1 |
| Bissell, M | 1 |
| Bonkovsky, H | 2 |
| Seay, T | 1 |
| Paw, B | 1 |
| Desnick, R | 1 |
| Bloomer, J | 1 |
| Snast, I | 1 |
| Kaftory, R | 1 |
| Sherman, S | 1 |
| Edel, Y | 1 |
| Hodak, E | 1 |
| Levi, A | 1 |
| Lapidoth, M | 1 |
| Wong, MY | 1 |
| Tang, HW | 1 |
| Man, SH | 1 |
| Lam, CW | 1 |
| Che, CM | 1 |
| Ng, KM | 1 |
| Oustric, V | 1 |
| Manceau, H | 1 |
| Ducamp, S | 3 |
| Soaid, R | 1 |
| Karim, Z | 1 |
| Schmitt, C | 1 |
| Mirmiran, A | 1 |
| Peoc'h, K | 1 |
| Grandchamp, B | 1 |
| Beaumont, C | 2 |
| Lyoumi, S | 2 |
| Moreau-Gaudry, F | 2 |
| Guyonnet-Dupérat, V | 1 |
| de Verneuil, H | 1 |
| Marie, J | 1 |
| Deybach, JC | 3 |
| Schubiger, C | 1 |
| Biolcati, G | 3 |
| Buonuomo, PS | 1 |
| Macchiaiolo, M | 1 |
| Gonfiantini, MV | 1 |
| Pitisci, A | 1 |
| Villani, A | 1 |
| Bartuli, A | 1 |
| Brancaleoni, V | 1 |
| Missineo, P | 1 |
| Fiorentino, V | 1 |
| Fustinoni, S | 1 |
| Naik, H | 2 |
| Landefeld, C | 1 |
| Kentouche, K | 1 |
| Gruhn, B | 1 |
| Stauch, T | 1 |
| Rößler, S | 1 |
| Schuppan, D | 1 |
| Whatley, SD | 2 |
| Beck, JF | 1 |
| Stölzel, U | 1 |
| Fratz, EJ | 1 |
| Clayton, J | 1 |
| Hunter, GA | 1 |
| Breydo, L | 2 |
| Uversky, VN | 2 |
| Ferreira, GC | 2 |
| Ninomiya, Y | 1 |
| Kokunai, Y | 1 |
| Tanizaki, H | 1 |
| Akasaka, E | 1 |
| Moriwaki, S | 1 |
| Gou, EW | 1 |
| Bissell, DM | 1 |
| Bonkovsky, HL | 1 |
| Wang, B | 1 |
| Keel, S | 1 |
| Elenbaas, JS | 1 |
| Maitra, D | 1 |
| Liu, Y | 1 |
| Lentz, SI | 1 |
| Nelson, B | 1 |
| Hoenerhoff, MJ | 1 |
| Shavit, JA | 1 |
| Omary, MB | 1 |
| Fratz-Berilla, EJ | 1 |
| Barman-Aksoezen, J | 1 |
| Girelli, D | 1 |
| Aurizi, C | 1 |
| Campostrini, N | 1 |
| Barbieri, L | 1 |
| Delaby, C | 1 |
| Martin-Schmitt, C | 1 |
| Martinez, Mdel C | 1 |
| Afonso, SG | 1 |
| Meiss, RP | 1 |
| Buzaleh, AM | 1 |
| Batlle, A | 1 |
| Blagojevic, D | 1 |
| Schenk, T | 1 |
| Haas, O | 1 |
| Zierhofer, B | 1 |
| Konnaris, C | 1 |
| Trautinger, F | 1 |
| Hanneken, S | 1 |
| Siegesmund, M | 1 |
| Bolsen, K | 1 |
| Gardlo, K | 1 |
| Neumann, NJ | 1 |
| Duchartre, Y | 1 |
| Petit, N | 1 |
| Moya, C | 1 |
| Lalanne, M | 1 |
| Dubus, P | 1 |
| Verneuil, Hd | 1 |
| Richard, E | 1 |
| Troadec, MB | 1 |
| Warner, D | 1 |
| Wallace, J | 1 |
| Thomas, K | 1 |
| Spangrude, GJ | 1 |
| Khalimonchuk, O | 1 |
| Paw, BH | 1 |
| Ward, DM | 1 |
| Kaplan, J | 1 |
| Liu, Q | 1 |
| Huang, W | 1 |
| Shindi, AA | 1 |
| Li, YQ | 1 |
| Zhou, S | 1 |
| Zong, Y | 1 |
| Ney, PA | 1 |
| Nair, G | 1 |
| Stewart, CF | 1 |
| Sorrentino, BP | 1 |
| Cooperman, SS | 1 |
| Meyron-Holtz, EG | 1 |
| Olivierre-Wilson, H | 1 |
| Ghosh, MC | 1 |
| McConnell, JP | 1 |
| Rouault, TA | 1 |
| Eefsen, M | 1 |
| Rasmussen, A | 1 |
| Brock, A | 1 |
| Hansen, BA | 1 |
| Mason, NG | 1 |
| Holme, SA | 2 |
| Anstey, AV | 3 |
| Elder, GH | 2 |
| Badminton, MN | 2 |
| Worwood, M | 1 |
| Wahlin, S | 1 |
| Harper, P | 1 |
| Hift, RJ | 1 |
| Childs, S | 1 |
| Weinstein, BM | 1 |
| Mohideen, MA | 1 |
| Donohue, S | 1 |
| Fishman, MC | 1 |
3 reviews available for protoporphyrin ix and Erythrohepatic Protoporphyria
| Article | Year |
|---|---|
Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics.
Topics: 5-Aminolevulinate Synthetase; Endothelial Cells; Humans; Protoporphyria, Erythropoietic; Protoporphy | 2023 |
Acquired erythropoietic protoporphyria: A systematic review of the literature.
Topics: Adult; Aged; Azacitidine; beta Carotene; Chromosomes, Human, Pair 18; Erythrocytes; Female; Ferroche | 2020 |
Liver disease in erythropoietic protoporphyria: insights and implications for management.
Topics: Animals; Disease Models, Animal; Humans; Liver Diseases; Liver Transplantation; Pedigree; Protoporph | 2007 |
3 trials available for protoporphyrin ix and Erythrohepatic Protoporphyria
| Article | Year |
|---|---|
Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria.
Topics: Action Spectrum; Administration, Cutaneous; Adolescent; Adult; Child; Female; Humans; Male; Middle A | 2018 |
In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Topics: 5-Aminolevulinate Synthetase; Adolescent; Adult; Erythrocytes; Female; Gene Expression Regulation, E | 2015 |
The prognostic value of cord blood analysis in erythropoietic protoporphyria: the 'Duesseldorf Cord Blood Study'.
Topics: Erythrocytes; Female; Ferrochelatase; Fetal Blood; Follow-Up Studies; Germany; Heme; Humans; Infant, | 2010 |
39 other studies available for protoporphyrin ix and Erythrohepatic Protoporphyria
| Article | Year |
|---|---|
Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
Topics: Erythrocytes; Ferrochelatase; Humans; Photochemotherapy; Protoporphyria, Erythropoietic; Protoporphy | 2022 |
Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria.
Topics: 5-Aminolevulinate Synthetase; Anemia, Sideroblastic; Animals; Disease Models, Animal; Female; Humans | 2019 |
The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Ferrochelatase; Liver; Mice; Mice, | 2019 |
Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality.
Topics: Adult; Extracorporeal Circulation; Female; Humans; Male; Middle Aged; Photochemotherapy; Protoporphy | 2020 |
Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Erythrocytes; Female; Ferrochel | 2020 |
Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming.
Topics: Denmark; Erythrocytes; Female; Hand; Humans; Light; Male; Photosensitivity Disorders; Protoporphyria | 2020 |
Erythropoietic protoporphyria- associated hepatopathy: expanding the spectra of brown pigments encountered in hepatic specimens.
Topics: Ferrochelatase; Humans; Liver Diseases; Male; Middle Aged; Mutation; Protoporphyria, Erythropoietic; | 2021 |
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
Topics: Cells, Cultured; Erythrocytes; Glycine Plasma Membrane Transport Proteins; Humans; K562 Cells; Molec | 2021 |
Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.
Topics: Erythrocytes; Humans; Protoporphyria, Erythropoietic; Protoporphyrins; Transferrins | 2022 |
Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.
Topics: 5-Aminolevulinate Synthetase; Cimetidine; Gastrointestinal Agents; Humans; Lactulose; Liver; Liver C | 2017 |
Osteoporosis in patients with erythropoietic protoporphyria.
Topics: Adolescent; Adult; Aged; Bone Density; Bone Density Conservation Agents; Cross-Sectional Studies; Fe | 2017 |
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.
Topics: 5-Aminolevulinate Synthetase; Cation Transport Proteins; Cell Line, Transformed; Ferrochelatase; Hum | 2019 |
Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Topics: 5-Aminolevulinate Synthetase; Biosynthetic Pathways; Ferrochelatase; Humans; Iron; Iron Regulatory P | 2019 |
Electrospray ionization on porous spraying tips for direct sample analysis by mass spectrometry: enhanced detection sensitivity and selectivity using hydrophobic/hydrophilic materials as spraying tips.
Topics: Diffusion; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Polyesters; Polyeth | 2013 |
Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
Topics: Cell Line; Female; Ferrochelatase; Humans; Male; Oligonucleotides, Antisense; Pedigree; Polymorphism | 2014 |
Erythropoietic protoporphyria in a boy.
Topics: Child; Humans; Male; Photosensitivity Disorders; Protoporphyria, Erythropoietic; Protoporphyrins | 2015 |
X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria.
Topics: Alleles; Erythrocytes; Female; Genes, X-Linked; Genetic Diseases, X-Linked; Genotype; Humans; Male; | 2016 |
X-linked protoporphyria: Iron supplementation improves protoporphyrin overload, liver damage and anaemia.
Topics: 5-Aminolevulinate Synthetase; Anemia; Child; Humans; Iron; Liver; Liver Diseases; Male; Protoporphyr | 2016 |
Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Enzyme Stability; Escherichia coli; Genetic Disea | 2015 |
X-linked dominant protoporphyria: The first reported Japanese case.
Topics: 5-Aminolevulinate Synthetase; Alleles; Cheek; Child; Diagnosis, Differential; Ferrochelatase; Geneti | 2016 |
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias.
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnosis, Differential; Erythrocytes; Female; Fluoromet | 2015 |
A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress.
Topics: Aminolevulinic Acid; Animals; Deferoxamine; Disease Models, Animal; Genetic Predisposition to Diseas | 2016 |
Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria.
Topics: Case-Control Studies; Erythema; Female; Fluorescence; Humans; Male; Photobleaching; Protoporphyria, | 2016 |
Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients.
Topics: 5-Aminolevulinate Synthetase; Anemia, Sideroblastic; Enzyme Inhibitors; Genetic Diseases, X-Linked; | 2017 |
Patients with erythropoietic protoporphyria have reduced erythrocyte protoporphyrin IX from early in pregnancy.
Topics: Adult; Erythrocytes; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Proto | 2017 |
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Topics: Anemia, Hypochromic; Case-Control Studies; Erythrocytes; Female; Ferritins; Ferrochelatase; Growth D | 2017 |
Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
Topics: Adolescent; Adult; Child; Erythrocytes; Erythropoiesis; Female; Humans; Iron; Lipids; Liver Function | 2009 |
Hepatic damage and oxidative stress induced by Griseofulvin in mice.
Topics: Animals; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Cytochrome P-450 | 2009 |
Acquired erythropoietic protoporphyria.
Topics: Aged; beta Carotene; Humans; Male; Myelodysplastic Syndromes; Protoporphyria, Erythropoietic; Protop | 2010 |
Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Topics: Animals; Animals, Newborn; Bone Marrow Transplantation; Busulfan; Disease Models, Animal; Disease Pr | 2011 |
Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria.
Topics: Anemia; Animals; Base Sequence; DNA Primers; Embryo Loss; Female; Gene Targeting; Heme; Hepatocytes; | 2011 |
A novel rapid method for simultaneous determination of three diagnostically important porphyrins in erythrocytes using hyphenated synchronous fluorescence techniques.
Topics: Biomarkers; Coproporphyrins; Erythrocytes; Humans; Limit of Detection; Protoporphyria, Erythropoieti | 2012 |
Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; | 2005 |
Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
Topics: Anemia; Animals; Bone Marrow; Erythroid Precursor Cells; Erythropoiesis; Ferritins; Iron; Iron Regul | 2005 |
Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices.
Topics: Adult; Erythrocytes; Humans; Liver Failure; Liver Transplantation; Male; Osmolar Concentration; Phot | 2007 |
Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria.
Topics: DNA Mutational Analysis; Exons; Family Health; Ferrochelatase; Gene Deletion; Gene Dosage; Haplotype | 2007 |
Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
Topics: Anemia; Antigens, CD; Cross-Sectional Studies; Erythrocytes; Erythropoiesis; Female; Ferritins; Ferr | 2007 |
Pretransplant albumin dialysis in erythropoietic protoporphyria: a costly detour.
Topics: Erythrocytes; Humans; Liver Failure; Liver Transplantation; Plasmapheresis; Preoperative Care; Proto | 2007 |
Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria.
Topics: Animals; Disease Models, Animal; Ferrochelatase; Hemolysis; Humans; Light; Liver Diseases; Mutation; | 2000 |